Latest Period
Q1 2026
Security Snapshot
PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) Institutional Ownership
CUSIP: 729139105
13F Institutional Holders and Ownership History from Q2 2020 to Q1 2026
Institutions Reporting
89
Shares (Excl. Options)
49,680,361
Price
$1.26
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- PLRX on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 49,680,361
- Total 13F value
- $62,482,493
- Portfolio coverage rank
- 0%
- Share change
- +3,043,343
- Value change
- +$3,349,912
- Number of holders
- 89
- Shares outstanding
- 61,399,727
- SEC-reported price per share
- $1.18
- Insider filing price
- $1.18
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- PLRX - PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share is tracked under CUSIP 729139105.
- 89 institutions reported positions in Q1 2026.
- 10 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 95 to 89 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $57,540,105 to $62,482,493.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 89 institutions filings for Q1 2026.
Security key
729139105
Latest holder period
Q1 2026
13F holders
89
13D/G owners
10
CIK / CUSIP context first
Open Q1 2026 holders
PLRX full holder history
PLIANT THERAPEUTICS, INC. SEC filings
PLIANT THERAPEUTICS, INC. company facts
PLIANT THERAPEUTICS, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 729139105:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
10
Security
PLRX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 9.6% | $9,198,699 | 5,859,044 | TANG CAPITAL MANAGEMENT, LLC | 03 Mar 2025 | |||
| CITADEL ADVISORS LLC | 5% | +2% | $3,711,402 | +$5,414 | 3,042,133 | +0.15% | Kenneth Griffin | 02 Feb 2026 |
| VANGUARD GROUP INC | 4.9% | $3,482,724 | 3,002,348 | The Vanguard Group | 30 Jun 2025 | |||
| Redmile Group, LLC | 4.8% | $4,545,900 | 2,895,478 | Redmile Group, LLC | 31 Dec 2024 | |||
| BlackRock, Inc. | 3.4% | $2,440,674 | 2,104,574 | BlackRock, Inc. | 30 Jun 2025 | |||
| Woodline Partners LP | 3.3% | -57% | $2,471,953 | -$3,023,924 | 2,026,191 | -55% | Woodline Partners LP | 31 Dec 2025 |
| MORGAN STANLEY | 0.9% | -87% | $861,460 | -$5,043,529 | 545,228 | -85% | Morgan Stanley | 31 Dec 2025 |
| FMR LLC | 0.2% | $207,230 | 131,993 | FMR LLC | 28 Feb 2025 | |||
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.1% | $137,648 | 87,674 | T. Rowe Price Associates, Inc. | 31 Mar 2025 | |||
| Point72 Asset Management, L.P. | 0.1% | -94% | $56,775 | -$4,926,946 | 46,537 | -99% | Point72 Asset Management, L.P. | 31 Dec 2025 |
As of 31 Mar 2026, 89 institutional investors reported holding 49,680,361 shares of PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX). This represents 81% of the company’s total 61,399,727 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
68%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 10% | 6,143,132 | 0% | 0.39% | $7,740,346 |
| CITADEL ADVISORS LLC | 5.3% | 3,226,599 | +25% | 0% | $4,065,514 |
| Blue Owl Capital Holdings LP | 4.8% | 2,969,199 | 0% | 1% | $3,741,191 |
| ADAR1 Capital Management, LLC | 4.2% | 2,585,126 | +3402% | 0.2% | $3,257,259 |
| ACADIAN ASSET MANAGEMENT LLC | 3.9% | 2,416,508 | +2.2% | 0% | $3,038,000 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.8% | 2,343,101 | 0% | 0% | $2,952,307 |
| TWO SIGMA INVESTMENTS, LP | 3.7% | 2,253,138 | +136% | 0% | $2,838,954 |
| Monaco Asset Management SAM | 3.2% | 1,938,747 | 0% | 0.78% | $2,442,821 |
| RENAISSANCE TECHNOLOGIES LLC | 3% | 1,852,842 | +77% | 0% | $2,334,581 |
| Prosight Management, LP | 2.7% | 1,667,600 | +7.2% | 0.34% | $2,101,176 |
| Woodline Partners LP | 2.7% | 1,666,830 | -18% | 0.01% | $2,100,206 |
| BML Capital Management, LLC | 2.5% | 1,546,137 | 0% | 1.3% | $1,948,133 |
| Peapod Lane Capital LLC | 2.1% | 1,288,578 | +45% | 1.3% | $1,589,284 |
| MILLENNIUM MANAGEMENT LLC | 1.9% | 1,180,518 | +189% | 0% | $1,487,453 |
| BlackRock, Inc. | 1.8% | 1,096,430 | +2.2% | 0% | $1,381,502 |
| UBS Group AG | 1.7% | 1,057,954 | -0.44% | 0% | $1,333,022 |
| MARSHALL WACE, LLP | 1.6% | 995,973 | -7.8% | 0% | $1,254,925 |
| Eversept Partners, LP | 1.5% | 891,425 | +5.9% | 0.07% | $1,123,196 |
| JPMORGAN CHASE & CO | 1.4% | 861,823 | -29% | 0% | $1,012,642 |
| Redmile Group, LLC | 1.3% | 772,126 | -52% | 0.06% | $972,879 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.2% | 718,543 | +29% | 0% | $905,364 |
| GOLDMAN SACHS GROUP INC | 0.97% | 596,837 | +116% | 0% | $752,014 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.9% | 553,630 | +72% | 0.01% | $697,574 |
| BESSEMER GROUP INC | 0.87% | 532,079 | 0% | 0% | $670,000 |
| Connor, Clark & Lunn Investment Management Ltd. | 0.84% | 517,453 | +39% | 0% | $651,991 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
24
Latest
Q1 2026
Rows shown
1-24 of 24
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 49,680,361 | $62,482,493 | +$3,349,912 | $1.26 | 89 |
| 2025 Q4 | 46,690,012 | $57,540,105 | -$7,186,194 | $1.22 | 95 |
| 2025 Q3 | 50,406,732 | $74,592,710 | +$1,536,181 | $1.48 | 97 |
| 2025 Q2 | 51,491,424 | $59,725,484 | -$8,565,167 | $1.16 | 112 |
| 2025 Q1 | 57,869,854 | $78,126,006 | -$216,549,992 | $1.35 | 138 |
| 2024 Q4 | 64,754,179 | $852,599,671 | +$21,507,892 | $13.17 | 158 |
| 2024 Q3 | 63,483,171 | $714,277,363 | -$5,607,911 | $11.21 | 149 |
| 2024 Q2 | 63,896,951 | $686,885,070 | -$18,557,994 | $10.75 | 141 |
| 2024 Q1 | 65,187,064 | $971,256,923 | +$41,504,855 | $14.90 | 133 |
| 2023 Q4 | 62,712,668 | $1,135,768,923 | +$100,850,737 | $18.11 | 133 |
| 2023 Q3 | 60,161,028 | $1,043,150,835 | +$29,447,949 | $17.34 | 134 |
| 2023 Q2 | 58,042,121 | $1,051,734,729 | +$9,423,269 | $18.12 | 141 |
| 2023 Q1 | 56,237,135 | $1,495,380,265 | +$312,862,520 | $26.60 | 143 |
| 2022 Q4 | 44,702,851 | $864,087,630 | -$14,811,927 | $19.33 | 123 |
| 2022 Q3 | 45,386,319 | $948,113,021 | +$327,405,105 | $20.89 | 107 |
| 2022 Q2 | 30,133,558 | $241,439,678 | -$11,245,591 | $8.01 | 81 |
| 2022 Q1 | 31,426,255 | $220,339,413 | +$4,111,275 | $7.01 | 85 |
| 2021 Q4 | 30,850,148 | $416,473,043 | +$5,468,177 | $13.50 | 81 |
| 2021 Q3 | 30,380,086 | $512,798,759 | -$14,863,235 | $16.88 | 75 |
| 2021 Q2 | 30,676,131 | $893,270,740 | -$1,364,693 | $29.12 | 80 |
| 2021 Q1 | 30,719,770 | $1,208,139,215 | +$88,069,181 | $39.33 | 76 |
| 2020 Q4 | 28,511,470 | $647,801,804 | +$7,265,154 | $22.72 | 57 |
| 2020 Q3 | 28,195,401 | $635,735,229 | +$17,040,139 | $22.65 | 53 |
| 2020 Q2 | 26,908,341 | $868,442,000 | +$868,442,000 | $32.46 | 36 |